Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Investigation of Rare Non-Coding Variants in Familial Multiple Myeloma

Y. Niazi, N. Paramasivam, J. Blocka, A. Kumar, S. Huhn, M. Schlesner, N. Weinhold, R. Sijmons, M. De Jong, B. Durie, H. Goldschmidt, K. Hemminki, A. Försti

. 2022 ; 12 (1) : . [pub] 20221226

Language English Country Switzerland

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc23004886

Multiple myeloma (MM) is a plasma cell malignancy whereby a single clone of plasma cells over-propagates in the bone marrow, resulting in the increased production of monoclonal immunoglobulin. While the complex genetic architecture of MM is well characterized, much less is known about germline variants predisposing to MM. Genome-wide sequencing approaches in MM families have started to identify rare high-penetrance coding risk alleles. In addition, genome-wide association studies have discovered several common low-penetrance risk alleles, which are mainly located in the non-coding genome. Here, we further explored the genetic basis in familial MM within the non-coding genome in whole-genome sequencing data. We prioritized and characterized 150 upstream, 5' untranslated region (UTR) and 3' UTR variants from 14 MM families, including 20 top-scoring variants. These variants confirmed previously implicated biological pathways in MM development. Most importantly, protein network and pathway enrichment analyses also identified 10 genes involved in mitogen-activated protein kinase (MAPK) signaling pathways, which have previously been established as important MM pathways.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23004886
003      
CZ-PrNML
005      
20230425171757.0
007      
ta
008      
230418s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/cells12010096 $2 doi
035    __
$a (PubMed)36611892
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Niazi, Yasmeen $u Hopp Children's Cancer Center (KiTZ), 69120 Heidelberg, Germany $u Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), 69120 Heidelberg, Germany $1 https://orcid.org/0000000275602247
245    10
$a Investigation of Rare Non-Coding Variants in Familial Multiple Myeloma / $c Y. Niazi, N. Paramasivam, J. Blocka, A. Kumar, S. Huhn, M. Schlesner, N. Weinhold, R. Sijmons, M. De Jong, B. Durie, H. Goldschmidt, K. Hemminki, A. Försti
520    9_
$a Multiple myeloma (MM) is a plasma cell malignancy whereby a single clone of plasma cells over-propagates in the bone marrow, resulting in the increased production of monoclonal immunoglobulin. While the complex genetic architecture of MM is well characterized, much less is known about germline variants predisposing to MM. Genome-wide sequencing approaches in MM families have started to identify rare high-penetrance coding risk alleles. In addition, genome-wide association studies have discovered several common low-penetrance risk alleles, which are mainly located in the non-coding genome. Here, we further explored the genetic basis in familial MM within the non-coding genome in whole-genome sequencing data. We prioritized and characterized 150 upstream, 5' untranslated region (UTR) and 3' UTR variants from 14 MM families, including 20 top-scoring variants. These variants confirmed previously implicated biological pathways in MM development. Most importantly, protein network and pathway enrichment analyses also identified 10 genes involved in mitogen-activated protein kinase (MAPK) signaling pathways, which have previously been established as important MM pathways.
650    _2
$a lidé $7 D006801
650    12
$a celogenomová asociační studie $7 D055106
650    12
$a mnohočetný myelom $x genetika $7 D009101
650    _2
$a MAP kinasový signální systém $7 D020935
650    _2
$a sekvenování celého genomu $7 D000073336
650    _2
$a zárodečné mutace $7 D018095
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Paramasivam, Nagarajan $u Computational Oncology, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany
700    1_
$a Blocka, Joanna $u Department of Internal Medicine V, University of Heidelberg, 69120 Heidelberg, Germany $u Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA 02115, USA $u Harvard Medical School, Boston, MA 02115, USA
700    1_
$a Kumar, Abhishek $u Institute of Bioinformatics, International Technology Park, Bangalore 560066, India $u Manipal Academy of Higher Education (MAHE), Manipal 576104, India
700    1_
$a Huhn, Stefanie $u Department of Internal Medicine V, University of Heidelberg, 69120 Heidelberg, Germany $u National Center for Tumor Diseases Heidelberg (NCT), 69120 Heidelberg, Germany
700    1_
$a Schlesner, Matthias $u Bioinformatics and Omics Data Analytics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
700    1_
$a Weinhold, Niels $u Department of Internal Medicine V, University of Heidelberg, 69120 Heidelberg, Germany
700    1_
$a Sijmons, Rolf $u University Medical Center Groningen, University of Groningen, 9712 Groningen, The Netherlands
700    1_
$a De Jong, Mirjam $u University Medical Center Groningen, University of Groningen, 9712 Groningen, The Netherlands
700    1_
$a Durie, Brian $u Cedars Sinai Cancer Center, Los Angeles, CA 90048, USA
700    1_
$a Goldschmidt, Hartmut $u Computational Oncology, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany $u Department of Internal Medicine V, University of Heidelberg, 69120 Heidelberg, Germany $1 https://orcid.org/0000000309610035
700    1_
$a Hemminki, Kari $u Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany $u Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, 323 00 Pilsen, Czech Republic $1 https://orcid.org/0000000227693316 $7 mzk20201092711
700    1_
$a Försti, Asta $u Hopp Children's Cancer Center (KiTZ), 69120 Heidelberg, Germany $u Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), 69120 Heidelberg, Germany $1 https://orcid.org/0000000298574728
773    0_
$w MED00194911 $t Cells $x 2073-4409 $g Roč. 12, č. 1 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36611892 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20230425171753 $b ABA008
999    __
$a ok $b bmc $g 1925150 $s 1191095
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 12 $c 1 $e 20221226 $i 2073-4409 $m Cells $n Cells $x MED00194911
LZP    __
$a Pubmed-20230418

Find record

Citation metrics

Archiving options